Antineoplastic AgentsRadiation DosageRadiation, IonizingRadiation InjuriesDose-Response Relationship, RadiationRadiation ToleranceRadiationDrug Screening Assays, AntitumorCell Line, TumorRadiation ProtectionRadiation MonitoringNeoplasmsDoxorubicinApoptosisDrug Resistance, NeoplasmRadiation OncologyCell SurvivalAntineoplastic Agents, PhytogenicCisplatinAntibiotics, AntineoplasticCosmic RadiationDrug Delivery SystemsRadiation Injuries, ExperimentalGamma RaysTumor Cells, CulturedRadiation PneumonitisDrug CarriersDNA DamageXenograft Model Antitumor AssaysMice, NudeNeoplasms, Radiation-InducedRadiation-Sensitizing AgentsRadiotherapyBackground RadiationEllipticinesCell ProliferationUltraviolet RaysEtoposideCamptothecinPaclitaxelCombined Modality TherapyRadiometryRadiotherapy DosageDrug Resistance, MultipleInhibitory Concentration 50P-GlycoproteinRadiation EffectsMolecular StructureDose-Response Relationship, DrugCell CycleDrug DesignBreast NeoplasmsDrug SynergismRadiation-Protective AgentsDNA Topoisomerases, Type IIProdrugsDNA RepairEnzyme InhibitorsTime FactorsFluorouracilAcute Radiation SyndromeTopoisomerase I InhibitorsGene Expression Regulation, NeoplasticDaunorubicinNanoparticlesNanomedicineDrug Evaluation, PreclinicalTumor Suppressor Protein p53Plant ExtractsPlatinumColonic NeoplasmsX-RaysDrug DiscoveryNanocapsulesAntimetabolites, AntineoplasticDNACaspasesRadioactive Hazard ReleaseNeoplasm TransplantationNeoplasms, ExperimentalAntineoplastic Combined Chemotherapy ProtocolsCobalt RadioisotopesRadiobiologyRadiotherapy, ConformalOrganoplatinum CompoundsRadiation Hybrid MappingSignal TransductionCaspase 3Proto-Oncogene Proteins c-bcl-2Antineoplastic Agents, AlkylatingBrain NeoplasmsMolecular Targeted TherapyCell DivisionMitoxantroneCell DeathMitomycinDose FractionationDrugs, InvestigationalNeoplasm ProteinsDNA Adducts